MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from public
offering of common stock,...
$53,610K
Proceeds from exercise of
stock options
$507K
Proceeds from employee
stock purchase plan
$103K
Net cash provided by
financing activities
$54,026K
Canceled cashflow
$194K
Net (decrease)
increase in cash and cash...
-$99K
Canceled cashflow
$54,026K
Proceeds from maturities
and sales of...
$59,836K
Stock-based compensation
$5,110K
Depreciation and
amortization
$940K
Accrued and other
current liabilities
$682K
Non-cash lease expense
$492K
Non-cash investment
income, net
-$314K
Deferred revenue
$92K
Accounts receivable
-$22K
Other receivables
-$19K
Finance lease principal
payments
$194K
Net cash (used in)
provided by investing...
-$28,502K
Canceled cashflow
$59,836K
Net cash used in
operating activities
-$25,623K
Canceled cashflow
$7,671K
Other income, net
$4,585K
Purchases of marketable
securities
$87,612K
Purchases of property and
equipment
$726K
Net loss
-$31,928K
Canceled cashflow
$4,585K
Accounts payable
-$1,009K
Prepaid expenses and
other assets
$352K
Other
$5K
Revenue
$81K
Loss from operations
-$36,504K
Canceled cashflow
$81K
Interest expense
$9K
Payroll related
expenses
$16,745K
Consulting and
professional fees
$6,944K
Stock-based compensation
expense
$5,110K
Other segment items
$3,692K
Clinical studies and
outside processing
$1,579K
Equipment, lab supplies,
and facility...
$1,527K
Depreciation and
amortization
$824K
Cost of revenue
$164K
Back
Back
Cash Flow
source: myfinsight.com
SERA PROGNOSTICS, INC. (SERA)
SERA PROGNOSTICS, INC. (SERA)